intensive care setting News
-
Abionic Successfully Raises CHF20 Million in Series C Financing
Abionic SA, a developer of disruptive nanotechnology based rapid diagnostic solutions, announced today the successful closing of a CHF20 million Series C financing. The round was led by Pierangelo Bottinelli, Chairman of Symphony International Holdings Limited, and included Philippe Glatz (Chairman of two private hospitals), Peter Brabeck-Letmathe (former CEO and Chairman of Nestlé), ...
By Abionic SA
-
Healthcare Associated Infection Exposed in New Public Outreach Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. The online video, Acinetobacter, was developed to educate the general public and healthcare providers about this potentially deadly bacterial pathogen often linked with healthcare associated infection (HAIs). Acinetobacter is a group of bacteria commonly found in soil and ...
-
Microbial Outbreak Results in Deaths at Neonatal Intensive Care Unit
Cinnaminson, NJ, August 8th, 2012 The Health Minister of the Bahamas recently ordered an investigation into an outbreak of a microbial pathogen at a neonatal intensive care unit. The outbreak, caused by a type of bacteria known as Acinetobacter baumannii, is believed to have sickened eight infants and caused two of the infants to die. Outbreaks of Acinetobacter baumannii in healthcare ...
-
Midwest Hospitals on the Lookout for MDR-AB
In November of last year, a new study was published in the American Journal of Infection Control (AJIC). It indicated the common presence of Acinetobacter baumannii (MDR-AB), a dangerous multi-drug resistant bacterium, in numerous patient rooms in healthcare settings. Researchers found that MDR-AB was present in the indoor environment of 48% of the rooms of patients infected or colonized by the ...
-
Maryland Scientists Identify High Rates of Dangerous Bacteria Growth in Infected Patient Rooms
Scientists from the University of Maryland’s School of Medicine recently conducted research into the presence of multi-drug resistant Acinetobacter baumannii (MDR-AB) in patient rooms in medical facilities. The research was published in the American Journal of Infection Control (AJIC). Researchers found that MDR-AB was present in the environment of 48% of the rooms of patients infected ...
-
Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective, rapid, ...
-
It All Starts With Patient Safety at Medovate
When Medovate was spun out of the National Health Service (NHS) in 2017, one of the key priorities was to ensure that each medical device the company developed added real value to patient safety. The company mission is to “improve patient care and safety by supplying innovative Medtech solutions inspired by clinicians and developed in partnership with the NHS.” Through a unique ...
By Medovate
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you